67
Participants
Start Date
March 31, 2013
Primary Completion Date
September 30, 2014
Study Completion Date
September 30, 2014
NNZ-2566
Glycyl-L-2-Methylpropyl-L-Glutamic Acid (NNZ-2566) supplied as a lyophilized powder (2g in 50mL vials) for reconstitution with strawberry flavored solution 0.5% v/v in Water for Injection.
Placebo
Strawberry flavored solution and Water for Injection
Gillette Children's Specialty Healthcare, Saint Paul
Baylor School of Medicine, Houston
University of Alabama, Birmingham
Lead Sponsor
Baylor College of Medicine
OTHER
International Rett Syndrome Foundation
OTHER
Neuren Pharmaceuticals Limited
INDUSTRY